Nurix Therapeutics Inc. – Investors and Politicians Who Own It
NRIX
Investors who own it
7 tracked investors, $635.3M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
David KroinDeep Track Capital, Q2 2026 | $187.7M | 2.73% |
David RosenRubric Capital Management, Q2 2026 | $175.3M | 1.61% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $113M | 0.57% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $104.8M | 1.57% |
Cathie WoodARK Investment Management, Q2 2026 | $43.5M | 0.28% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $7.6M | 0.35% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $3.4M | 0.01% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| David Kroin | Reduced −22% | 3,000,000 |
| Peter Kolchinsky | New | 1,333,333 |
| Cathie Wood | Reduced −31% | 1,530,293 |
| Joseph Edelman | New | 330,614 |
| Darwin Global Management | New | 163,681 |
| Stanley Druckenmiller | Sold out | 0 |
| Daniel Schneeberger | New | 11,000 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.